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Background: The long-term outcome of patients with plumonary arterial hypertension associated with repaired congenital heart disease and 
Eisenmenger syndrome (ES) of Europe and American were contradictory, maybe the Chinese cohort data could strength our knowledge on this 
population.
methods: A prospective cohort study was undertaken in 626 consecutive patients with repaired congenital heart disease associated pulmonary 
arterial hypertension (CHD’-PAH), ES, or IPAH, in Modern therapy era. Survivals were assessed with Kaplan-Meier analysis. Multivariable Cox 
regression analyzed the prognostic predictor of patients with CHD’-PAH.
Results: 148 patients with CHD’-PAH, 103 patients with ES, and 375 patients with IPAH were included. PAH-specific and additional therapy had 
no difference among the three groups (p > 0.05). Kaplan-Meier survival estimates at seven years for ES, IPAH and CHD’-PAH were 71.2%, 49% and 
65.2%, respectively. There was no difference between the survival of patients with ES and CHD’-PAH (p = 0.343). The survival of patients with CHD’-
PAH was better than that of patients with IPAH (p = 0.006). Multivariable Cox regression analysis revealed that three worse prognostic predictors, 
including of male, worse WHO functional class, and lower mixed venous oxygen saturation(SvO2).
conclusions:  The survival of patients with CHD’-PAH is similar to that of ES, while it is better than that of IPAH. Male, worse WHO function class, 
and lower SvO2 are three risk factors for CHD’-PAH poorer outcome
